0
0.5
1
1.5
2+
Mortality
69%
Improvement
Relative Risk
Mortality (b)
75%
Ventilation
59%
ICU admission
22%
Progression
31%
Progression (b)
-25%
primary
Hospitalization time
-5%
Recovery
-2%
Ivermectin I-TECH LATE TREATMENT RCT
Is late treatment with ivermectin beneficial for COVID-19?
RCT 490 patients in Malaysia (May - October 2021)
Lower mortality (p=0.09) and ventilation (p=0.17), not sig.
c19ivm.org
Lim et al., JAMA, November 2021
Favors ivermectin
Favors control